Podcasts

PODCASTS

Our Podcast highlights notable figures within the longevity field. The goal is to create social and political action around the issues of combating age-related chronic conditions and increasing our number of healthy, disease-free years!

Episodes

  • H-SPAN Podcast EP 2: Matt Kaeberlein
    A4LI Podcast Ep:2 Matt Kaeberlein Press play to start listening to our second audio podcast with Matt Kaeberlein, Chief Science Officer at Optispan Ventures, Professor of Laboratory Medicine and Pathology at the University of Washington School of Medicine! Listen On Spotify
    PLAY AUDIO
  • H-SPAN Podcast EP 1: Eric Verdin
    A4LI Podcast Ep:1 Eric Verdin Press play to start listening to our first audio podcast with Eric Verdin, MDProfessor, Buck Institute for Research on Aging! Listen On Spotify
    PLAY AUDIO

Policy Discussions

  • August 2022 Policy Discussion Irina & Michael Conboy
    August 2022 Policy Discussion Discussion with Irina & Michael Conboy About this Event Irina and Michael Conboy are Professors at the University of California Berkley and the Department of Bioengineering. The Discussion covers Irina and Michael Conboy and their work at the Conboy Lab and how increasing funding for foundational research will change the longevity field. 
    PLAY
  • July 2022 Policy Discussion with Simon Rosenberg
    July 2022 Policy Discussion Discussion with Simon Rosenberg. About this Event Simon Rosenberg is a prominent American political strategist and founder of the New Policy Institute. The discussion covered how Simon moves policy issues onto party platforms, and how he thinks the merits of longevity medicine can best be communicated to policymakers. 
    PLAY
  • June 2022 Policy Discussion with Congressman Paul Tonko
    June 2022 Policy Discussion Discussion with Congressman Paul Tonko. About this Event Paul Tonko is an American politician serving as the U.S. representative for New York’s 20th congressional district. The discussion covered how Paul Tonko became interested in aging research and longevity medicine, as well as what steps can be taken to inform members of Congress about the potential ...
    PLAY
  • May 2022 Policy Discussion with Bernard Siegal
    May 2022 Policy Discussion Discussion with Bernard Siegal. About this Event Bernard Siegel is Executive Director of the Regenerative Medicine Foundation. The discussion covered (1) Bernie’s background as a lawyer and as a stem cell/regenerative medicine advocate; (2) what the aging biotech field can learn from the stem cell advocacy effort and other biotech fields; (3) how to successfully ...
    PLAY
  • April 2022 Policy Discussion with Andrew Scott
    April 2022 Policy Discussion Discussion with Andrew Scott. About this Event Andrew Scott is a British economist and Professor of Economics at the London Business School.
    PLAY
  • March 2022 Policy Discussion with Melanie D’Arrigo and James Peyer
    March 2022 Policy Discussion Discussion with Melanie D’Arrigo and James Peyer. About this Event Melanie D’Arrigo is the Democratic Congressional candidate for NY-3 and James Peyer is CEO of Cambrian Biopharma. The discussion covered James and Melanie’s background and specifically why they are passionate about healthcare, Melanie’s current healthcare policy priorities and what a geroscientist like James would like ...
    PLAY
  • February 2022 Policy Discussion with Andrew Steele & Damian Green
    February 2022 Policy Discussion Discussion with Andrew Steele and Damian Green. About this Event Andrew Steele is a scientist, writer and campaigner based in London, and author of Ageless: The New Science of Getting Older Without Getting Old. Damian Green is a Member of Parliament in the UK and Head of the All-Party Parliamentary Group on Longevity. The discussion ...
    PLAY
  • January 2022 Policy Discussion with Thomas Kalil
    January 2022 Policy Discussion Discussion with Thomas Kalil, Chief Innovation Officer at Schmidt Futures. About this Event Thomas Kalil is an expert on technology and innovation policy, and is currently the Chief Innovation Officer at Schmidt Futures. He was previously Deputy Director for Policy in the White House Office of Science and Technology Policy under President Obama, and was ...
    PLAY
  • Creating a Bipartisan Movement to Increase Healthy Lifespan in the US
    Creating a Bipartisan Movement to Increase Healthy Lifespan in the US Panel discussion on the role of Congress in the longevity medicine revolution and how make longevity a grassroots, bipartisan initiative. About this Event Please join A4LI (The Alliance for Longevity Initiatives) for a panel discussion and live question and answer virtual event, on December 9th from 5-6:30pm ...
    PLAY